Заболевания, передающиеся половым путем

[Dr.]

Наткулся случайно на
"The PRACTITIONER’S HANDBOOK for the MANAGEMENT OF STDs", очень хороший pdf-справочник по диагностике и лечению ИППП. Очень понравился стиль изложения, подозреваю что таких книг целый цикл, интересуюсь, нет ли у кого остальных? Интересует все по внутреним болезням . Наверное, КПК юзеры давно такое читают, поделитесь ссылками на руководства . Это я взял с [Ссылки доступны только зарегистрированным пользователям ]

[Наталья П.]

Заболевания, передающиеся половым путем

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
Ресурс для специалистов и пациентов
an excellent site for the public and professionals alike. Visitors need to register, but the site is totally free.
There is much here about any Chlamydia related topic, and the information has apparently been produced and peer reviewed by Chlamydia experts. This is undoubtedly the site for anyone wishing to know more about the Chlamydiae family.
The site is also available in Arabic, Chinese, French, German, Italian, Japanese, Portuguese, Russian, Spanish, and Thai.

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
Global prevalence and incidence of selected curable sexually transmitted infections
Можно скачать пдф.

Contents

Introduction
Background
Global Estimates
Chlamydia estimates, 1999
Gonorrhoea estimates, 1999
Syphilis estimates, 1999
Trichomoniasis estimates, 1999
Prevention
Antibiotic resistance
References

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
Microbiology of the Genitourinary System
In women, genital infections may cause a vaginal discharge, mucosal ulceration producing local discomfort and pain on intercourse, or pelvic inflammatory disease. Ongoing infection of the upper genital tract leads to infertility, ectopic pregnancies and chronic pelvic pain. In men, genital infection may cause urethral discharge, pain on voiding, and painful scrotal swellings. Genital ulcers are usually painful. Some diseases cause enlarged inguinal lymph nodes.

[Наталья П.]

[Ссылки доступны только зарегистрированным пользователям ]
Melbourne Sexual Health Centre
Ресурс для специалистов и пациентов

[Ссылки доступны только зарегистрированным пользователям ]
Management Guidelines

[Наталья П.]

National guideline on the diagnosis and treatment of gonorrhoea in adults 2005. London (England): British Association for Sexual Health and HIV
[Ссылки доступны только зарегистрированным пользователям ]

[dr.Agapov]

Наконец то CDC разродился новым STD Treatment Guidelines

[Изображения доступны только зарегистрированным пользователям]

Качать здесь: PDF (713 kb)
[Ссылки доступны только зарегистрированным пользователям ]

[dr.Agapov]

Public Health Agency of Canada опубликовало
Canadian Guidelines on Sexually Transmitted Infections 2006 Edition

[Изображения доступны только зарегистрированным пользователям]

Качать здесь 2.63 Mb
[Ссылки доступны только зарегистрированным пользователям ]

[Hogan]

Сергей Анатольевич! Не могу открыть! Интересно, только у меня так?

[dr.Agapov]

Тогда со страницы Агентства
[Ссылки доступны только зарегистрированным пользователям ]
Справа в углу под рисунком PDF Version

[Наталья П.]

Журнал "Оценка медицинских технологий"
Health Technol Assess. 2007 Mar;11(8):1-184.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; for the Chlamydia Screening Studies Project Group.

Department of Preventive Medicine, University of Bristol, UK.

OBJECTIVES: To investigate epidemiological, social, diagnostic and economic aspects of chlamydia screening in non-genitourinary medicine settings.
METHODS: Linked studies around a cross-sectional population-based survey of adult men and women invited to collect urine and (for women) vulvovaginal swab specimens at home and mail these to a laboratory for testing for Chlamydia trachomatis. Specimens were used in laboratory evaluations of an amplified enzyme immunoassay (PCE EIA) and two nucleic acid amplification tests [Cobas polymerase chain reaction (PCR), Becton Dickinson strand displacement amplification (SDA)]. Chlamydia-positive cases and two negative controls completed a risk factor questionnaire. Chlamydia-positive cases were invited into a randomised controlled trial of partner notification strategies. Samples of individuals testing negative completed psychological questionnaires before and after screening. In-depth interviews were conducted at all stages of screening. Chlamydia transmission and cost-effectiveness of screening were investigated in a transmission dynamic model.
SETTING AND PARTICIPANTS: General population in the Bristol and Birmingham areas of England. In total, 19,773 women and men aged 16-39 years were randomly selected from 27 general practice lists.
RESULTS: Screening invitations reached 73% (14,382/19,773). Uptake (4731 participants), weighted for sampling, was 39.5% (95% CI 37.7, 40.8%) in women and 29.5% (95% CI 28.0, 31.0%) in men aged 16-39 years. Chlamydia prevalence (219 positive results) in 16-24 year olds was 6.2% (95% CI 4.9, 7.8%) in women and 5.3% (95% CI 4.4, 6.3%) in men. The case-control study did not identify any additional factors that would help target screening. Screening did not adversely affect anxiety, depression or self-esteem. Participants welcomed the convenience and privacy of home-sampling. The relative sensitivity of PCR on male urine specimens was 100% (95% CI 89.1, 100%). The combined relative sensitivities of PCR and SDA using female urine and vulvovaginal swabs were 91.8% (86.1, 95.7, 134/146) and 97.3% (93.1, 99.2%, 142/146). A total of 140 people (74% of eligible) participated in the randomised trial. Compared with referral to a genitourinary medicine clinic, partner notification by practice nurses resulted in 12.4% (95% CI -3.7, 28.6%) more patients with at least one partner treated and 22.0% (95% CI 6.1, 37.8%) more patients with all partners treated. The health service and patients costs (2005 prices) of home-based postal chlamydia screening were pound21.47 (95% CI pound19.91, 25.99) per screening invitation and pound28.56 (95% CI pound22.10, 30.43) per accepted offer. Preliminary modelling found an incremental cost-effectiveness ratio (2003 prices) comparing screening men and women annually to no screening in the base case of pound27,000/major outcome averted at 8 years. If estimated screening uptake and pelvic inflammatory disease incidence were increased, the cost-effectiveness ratio fell to pound3700/major outcome averted.
CONCLUSIONS: Proactive screening for chlamydia in women and men using home-collected specimens was feasible and acceptable. Chlamydia prevalence rates in men and women in the general population are similar. Nucleic acid amplification tests can be used on first-catch urine specimens and vulvovaginal swabs. The administrative costs of proactive screening were similar to those for opportunistic screening. Using empirical estimates of screening uptake and incidence of complications, screening was not cost-effective.

[Dr.Vad]

Новые рекомендации от CDC по лечению гонорреи:

[Ссылки доступны только зарегистрированным пользователям ]

[DrSusha]

Нет проблем

[Наталья П.]

Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006:

Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections

[Ссылки доступны только зарегистрированным пользователям ]